Antibodies in Drug Discovery: Identifying Novel Biomarkers to Overcome Sjögren’s Syndrome

Article   Aug 02, 2017 | by Dr. Petra Budde, Head of Medical Research, Protagen and Dr Peter Schulz-Knappe, Chief Scientific Officer, Protagen.

 
Antibodies in Drug Discovery: Identifying Novel Biomarkers to Overcome Sjögren’s Syndrome
 
 
 

RELATED ARTICLES

Rapid Detection of Designer Drugs Presents Challenges for Law Enforcement and Forensic Toxicology

Article

The rise of designer drugs is creating new challenges for both law enforcement and forensic toxicology laboratories, leading to new methods to identify and combat the often-deadly substances.

READ MORE

The Changing Role of Pathologists in the Age of Precision Medicine

Article

We spoke to Dr Philippe Taniere, Consultant Histopathologist/Molecular Pathology, and Dr Matthew Evans, Specialist Registrar at University Hospitals Birmingham, to learn how the role of pathologists is changing, what this means for oncologists and cancer patients, and some of the challenges these changes may present.

READ MORE

Types of Pollution: Have You Considered Pharmaceutical Waste?

Article

Despite regulation and legislation regarding the methods by which pharmaceutical companies must treat waste water, reports indicate that manufacturers are continuing to discharge untreated or inappropriately treated waste into the environment. The problem is having devastating impacts on human health, the environment and antimicrobial resistance is soaring.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Biopharma Cell Science Diagnostics Drug Discovery Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE